Zoetis Inc. (VIE:ZOTS)

Market Cap	54.39B
Revenue (ttm)	7.99B
Net Income (ttm)	2.22B
Shares Out	n/a
EPS (ttm)	4.95
PE Ratio	24.45
Forward PE	21.95
Dividend	1.75 (1.43%)
Ex-Dividend Date	Jul 18, 2025

Volume	n/a
Average Volume	4
Open	121.24
Previous Close	119.74
Day's Range	120.64 - 122.10
52-Week Range	119.74 - 181.56
Beta	n/a
RSI	36.22
Earnings Date	Nov 4, 2025

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ZOTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD